Cinanserin May Offer New Hope in Treating SARS
Jun 20, 2005 - 4:08:00 PM
|
|
|
"These findings demonstrate that the old drug cinanserin is an inhibitor of SARS-CoV replication, acting most likely via inhibition of the 3CL proteinase," say the researchers.
|
By American Society for Microbiology,
[RxPG] Cinanserin, a drug that underwent preliminary clinical testing on humans in the 1960's, may inhibit the SARS virus say researchers from Europe and China. Their findings appear in the June 2005 issue of the Journal of Virology.
Severe acute respiratory syndrome (SARS) emerged as a highly infectious respiratory disease in 2002 and reached epidemic levels within six months. An estimated 8,096 cases were reported resulting in 774 deaths throughout 29 countries. Although the causative agent was quickly identified as a new strain of the coronavirus, an effective method of treatment has yet to be determined.
In the study researchers scanned a database of 8,000 existing drugs for those that would likely bind to the 3C-like proteinase of SARS. Cinanserin, a well-characterized serotonin antagonist, scored high in the screening and was selected for further experimentation. The antiviral activity of cinanserin was evaluated in tissue samples containing the SARS virus and revealed a strong inhibition of coronavirus replication at nontoxic drug concentrations.
"These findings demonstrate that the old drug cinanserin is an inhibitor of SARS-CoV replication, acting most likely via inhibition of the 3CL proteinase," say the researchers.
Publication:
L. Chen, C. Gui, X. Luo, Q. Yang, S. Gunther, E. Scandella, C. Drosten, D. Bai, X. He, B. Ludewig, J. Chen, H. Luo, Y. Yang, Y. Yang, J. Zou, V. Thiel, K. Chen, J. Shen, X. Shen, H. Jiang. 2005. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. Journal of Virology, 79. 11: 7095-7103
On the web:
www.asm.org 
|
Advertise in this space for $10 per month.
Contact us today.
|
 |
|
Subscribe to SARS Newsletter
|
|
|
|
Additional information about the news article
|
The American Academy of Microbiology is the honorific leadership group within the American Society for Microbiology (ASM), the world's oldest life science organization. The AAM is the only group of its kind devoted entirely to microbiologists and the science of microbiology.
|
|
Feedback
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
|
Top of Page
|
